Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes

Completed · Not applicable

Conditions studied: NAFLD, Diabetes Mellitus

In brief

The primary objective of this pilot study is to assess the feasibility and acceptability of an intervention for improved detection and evidence-based care of NAFLD in Latinx and Black patients with type 2 diabetes (T2D) in Duke University Healthcare system (DUHS). We will enroll 10-15 Latinx and 10-15 Black patients with T2D and NAFLD, based on having mildly elevated liver enzymes (ALT \>/= 40 IU/mL in males, ALT \>/= 31 IU/mL in females) and exclusion of other liver diseases (e.g., viral hepatitis, alcohol abuse). Intervention content will include: 1) NAFLD education; 2)diet/lifestyle support; 3) T2D medication management; and 4) clinically-indicated liver testing and care. Intervention feasibility will be evaluated by examining recruitment rates, retention rates, and study visit completion rates. Acceptability will be assessed by survey and through qualitative interviews. The project objectives and intervention are minimal risk. The expected risks will not exceed those of usual care.

Key facts

Study ID

NCT05844137

Run by

Duke University

People needed

10

Starts

2023-09-18

Expected to finish

2024-01-29

Last updated by the study team

2024-12-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• People who identify as either: Latino/Latina/Hispanic ethnicity and/or Black or African American race
• People with type 2 diabetes (T2D), as defined by ICD-10 codes E11.xx.
• Patients with elevated serum alanine aminotransferase (ALT) within Duke University Healthcare System (DUHS). Elevated ALT will be defined as having at least two ALT ≥40 IU/mL in males or ≥31 IU/mL in females in the preceding 12 months

You may not qualify if…

• People with hepatitis B or C infection
• People with known alcohol overuse
• People with current use of chemotherapy or other drugs known to affect liver function
• People who have not been seen by a DUHS Primary Care Physician (PCP) or Endocrinologist in the preceding year.

Where it is running

• Duke University Healthcare System — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.